Long-term follow-up of spinal and bulbar muscular atrophy in Taiwan

被引:14
|
作者
Fu, Ser-Chen [1 ,2 ,3 ]
Kuo, Hung-Chou [1 ,2 ]
Chu, Chun-Che [1 ,2 ]
Wu, Yih-Ru [1 ,2 ]
Ro, Long-Sun [1 ,2 ]
Liu, Chin-San [3 ]
Huang, Chin-Chang [4 ]
机构
[1] Chang Gung Mem Hosp Linkou, Dept Neurol, Taipei, Taiwan
[2] Chang Gung Univ, Taipei, Taiwan
[3] Buddhist Tzu Chi Gen Hosp, Dept Neurol, Taipei, Taiwan
[4] Changhua Christian Hosp, Dept Neurol, Changhua, Taiwan
关键词
Kennedy disease; spinal and bulbar muscular atrophy; Taiwan; X-linked recessive bulbospinal muscular atrophy; RECESSIVE BULBOSPINAL NEURONOPATHY; ANDROGEN-RECEPTOR GENE; KENNEDY-DISEASE; NATURAL-HISTORY; CAG-REPEAT; FEATURES; FAMILY; SBMA; NEUROPATHY; EXPANSION;
D O I
10.1016/j.jfma.2012.03.008
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background/Purpose: Spinal and bulbar muscular atrophy (SBMA), also known as Kennedy disease, is a rare neurodegenerative disorder presenting with insidious onset of weakness in bulbar and limb muscles. Information regarding long-term clinical and functional progression has been limited, especially for the Taiwanese population. The purpose of the study aimed to investigate early diagnosis and long-term prognosis of SBMA. Methods: We retrospectively analyzed 21 genetically confirmed SBMA patients who visited our hospital between 1993 and 2010, focusing on clinical symptoms, nerve conduction studies, and functional disability. We also analyzed the relationship between length of cytosine-adenine-guanine (CAG) repeats and age of disease onset. Results: Weakness developed at a mean age of 39 +/- 7 years (mean +/- standard deviation). The length of CAG repeats and age at onset of weakness showed inverse (but nonsignificant) correlation. The most common symptoms at initial presentation were hand tremor (86%), limb weakness (86%), and perioral fasciculation (76%). Creatine kinase (CK) was elevated in 17 out of 18 patients. Initial nerve conduction studies showed statistical difference from normal controls, especially decreased amplitudes of compound motor action potential (CMAP) and sensory nerve action potential (SNAP). Functional disability showed very slow progression, with only three patients becoming wheelchair-dependent during follow-up at a median age of 72 years. Conclusion: Patients with SBMA may present with a myriad of symptoms, including limbs weakness, tremor, muscle atrophy, and perioral fasciculations. Elevated serum CK and decreased CMAP and SNAP amplitudes were supportive laboratory findings of SBMA. Disease progression was gradual, and most patients remained functionally independent many years after the onset of weakness. Copyright (C) 2012, Elsevier Taiwan LLC & Formosan Medical Association. All rights reserved.
引用
收藏
页码:326 / 331
页数:6
相关论文
共 50 条
  • [1] LONG-TERM FOLLOW-UP OF SPINAL-FUSION IN SPINAL MUSCULAR-ATROPHY
    PIASECKI, JO
    MAHINPOUR, S
    LEVINE, DB
    CLINICAL ORTHOPAEDICS AND RELATED RESEARCH, 1986, (207) : 44 - 54
  • [2] Long-term Effects of Androgen Deprivation in a Patient with Spinal and Bulbar Muscular Atrophy - A Case Report with 14 Years of Follow-up
    Hijikata, Yasuhiro
    Hashizume, Atsushi
    Yamada, Shinichiro
    Ito, Daisuke
    Banno, Haruhiko
    Suzuki, Keisuke
    Sobue, Gen
    Katsuno, Masahisa
    INTERNAL MEDICINE, 2019, 58 (15) : 2231 - 2234
  • [3] LONG-TERM FOLLOW-UP STUDY OF RISDIPLAM IN PARTICIPANTS WITH SPINAL MUSCULAR ATROPHY (WeSMA)
    Tanvir, Imran
    Lim, Elise
    Shapouri, Sheila
    Shah, Rushabh
    Sun, Christy
    Seth, Gaurav
    MUSCLE & NERVE, 2024, 70 (03) : 603 - 603
  • [4] Long-term treatment with leuprorelin for spinal and bulbar muscular atrophy
    Hashizume, A.
    Katsuno, M.
    Suzuki, K.
    Hirakawa, A.
    Hijikata, Y.
    Yamada, S.
    Inagaki, T.
    Banno, H.
    Sobue, G.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 205 - 206
  • [5] Long-term treatment with leuprorelin for spinal and bulbar muscular atrophy
    Mitsumoto, Hiroshi
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2017, 88 (12): : 1004 - 1005
  • [6] Long-term follow-up study in patients with spinal muscular atrophy (SMA) receiving risdiplam treatment
    Tanvir, I
    Tam, S.
    O'Donnell, D.
    Shapouri, S.
    Lim, E.
    Shah, R.
    Sun, C.
    Seth, G.
    ANNALS OF NEUROLOGY, 2023, 94 : S119 - S119
  • [7] Long-term Follow-up (LTFU) of Onasemnogene Abeparvovec Gene Therapy in Spinal Muscular Atrophy (SMA)
    Day, J.
    Mendell, J.
    Finkel, R.
    Mercuri, E.
    Strauss, K.
    Kleyn, A.
    Chand, D.
    Tauscher-Wisniewski, S.
    Meriggioli, M.
    ANNALS OF NEUROLOGY, 2021, 90 : S151 - S152
  • [8] Long-Term Follow-Up (LTFU) of Onasemnogene Abeparvovec Gene Therapy in Spinal Muscular Atrophy (SMA)
    Mendell, Jerry
    Finkel, Richard
    Mercuri, Eugenio
    Strauss, Kevin
    Day, John
    Kleyn, Aaron
    Chand, Deepa
    Tauscher-Wisniewski, Sitra
    Meriggioli, Matthew
    NEUROLOGY, 2021, 96 (15)
  • [9] Long-term follow-up (LTFU) of onasemnogene abeparvovec gene therapy in spinal muscular atrophy (SMA)
    Mendell, J.
    Finkel, R.
    Mercuri, E.
    Strauss, K.
    Day, J.
    Kleyn, A.
    Chand, D.
    Tauscher-Wisniewski, S.
    Meriggioli, M.
    NEUROMUSCULAR DISORDERS, 2021, 31 : S132 - S133
  • [10] Long-term Follow-up of Pulmonary Function and Scoliosis in Patients With Duchenne's Muscular Dystrophy and Spinal Muscular Atrophy
    Chua, Kenon
    Tan, Chin Yik
    Chen, Zhaojin
    Wong, Hee Kit
    Lee, Eng Hin
    Tay, Stacy K. H.
    Ong, Hian Tat
    Goh, Daniel Y. T.
    Hui, James H. P.
    JOURNAL OF PEDIATRIC ORTHOPAEDICS, 2016, 36 (01) : 63 - 69